storage – Page 10 – Pharma.Tips

Improper sample storage during incoming material receipt – inspection-ready sampling justification

Investigating Improper Sample Storage During Incoming Material Receipt Improper sample storage during the receipt of incoming materials can lead to non-compliant conditions and subsequent quality failures in pharmaceutical manufacturing. Addressing…

Sampling SOP not followed during internal audit – GMP expectations for material sampling

Investigating Non-Compliance with Internal Audit SOPs for Material Sampling In the realm of pharmaceutical manufacturing, adherence to standard operating procedures (SOPs) is non-negotiable, particularly during internal audits. A scenario that…

Vendor change implemented without approval during routine supplier audit – supplier risk classification strategy

Unauthorized Vendor Change Noted During Routine Supplier Audit: An Investigation Framework In the pharmaceutical manufacturing environment, adherence to protocols during vendor change management is crucial to maintaining product integrity and…

Critical supplier risk not assessed during routine supplier audit – supplier risk classification strategy

Unveiling Critical Supplier Risk Assessment Gaps During Routine Audits In the world of pharmaceutical manufacturing, the integrity of raw materials is paramount. When critical supplier risks are overlooked during routine…

Supplier audit findings escalated during requalification – inspection questions regulators ask

Investigating Supplier Audit Findings During Requalification: A Guide for Pharma Professionals In the highly regulated pharmaceutical industry, ensuring that supplier audit findings are swiftly and effectively addressed is critical for…

Inadequate vendor qualification during regulatory inspection – supplier risk classification strategy

Inadequate Vendor Qualification Revealed During Regulatory Inspection: A Pragmatic Investigation Approach In the recent past, multiple pharmaceutical manufacturers faced challenges stemming from inadequate vendor qualifications. These challenges, often revealed during…

Critical supplier risk not assessed during supplier onboarding – evidence pack for vendor oversight

Assessing Critical Supplier Risks During Onboarding: An Investigative Approach In a highly regulated pharmaceutical landscape, the onboarding process for suppliers plays a critical role in ensuring consistent quality and compliance.…

Supplier audit findings escalated during routine supplier audit – how to prevent repeat supplier failures

Addressing Escalated Supplier Audit Findings for Continuous Quality Improvement Supplier audits are vital to maintaining the integrity of pharmaceutical manufacturing processes. When findings escalate during routine assessments, it can indicate…

Critical supplier risk not assessed during supplier onboarding – supplier risk classification strategy

Assessing Critical Supplier Risk During Onboarding: A Comprehensive Investigation In the pharmaceutical industry, the onboarding process of suppliers is critical to maintaining product quality and compliance. An oversight in assessing…

Vendor change implemented without approval during supplier onboarding – inspection questions regulators ask

Investigating Unapproved Vendor Changes During Supplier Onboarding In the pharmaceutical industry, the integrity of raw materials is critical to the safety, efficacy, and quality of products. An investigation into the…

Supplier audit findings escalated during supply disruption – audit CAPA remediation framework

Escalated Supplier Audit Findings During Supply Disruption: An Investigative Framework for CAPA Remediation In a landscape where supply chain robustness is paramount, the escalating findings from supplier audits can signal…

Supplier audit findings escalated during supplier onboarding – audit CAPA remediation framework

Framework for Remediating Supplier Audit Findings During Onboarding In the pharmaceutical industry, supplier audits are critical for ensuring the quality and compliance of raw materials. Issues identified during audits can…